GSK-3368715

N/A

Report date: 2022/07/07 14:09:01
NME

Base Information

Drug NameGSK-3368715
Drug Alias NameGSK-3368715
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine N-methyltransferase 1 inhibitors
TargetsProtein arginine N-methyltransferase 1
Therapy Area/IndicationsLymphoma, Large B-Cell, DiffuseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A